Literature DB >> 12566794

The social cost of alcohol, tobacco and illicit drugs in France, 1997.

Philippe Fenoglio1, Véronique Parel, Pierre Kopp.   

Abstract

UNLABELLED: AIM, DESIGN AND
SETTING: The economic costs of alcohol, tobacco and illicit drugs to French society are estimated using a cost of illness framework. MEASUREMENTS: For the cause of disease or death (using ICD-9 categories), pooled relative risk estimates from meta-analyses were combined with prevalence data by age and gender to derive the proportion attributable to alcohol, tobacco and/or illicit drugs. The resulting estimates of attributable deaths and hospitalizations were used to calculate the associated health care, law enforcement, productivity and other costs. The results were compared with those of other studies, and sensitivity analyses were conducted by alternative ways of measuring risk attribution and costs.
FINDINGS: The use of alcohol, tobacco and illicit drugs cost more than 200 billion francs (FF) in France in 1997, representing 3714 FF per capita or 2.7% of the gross domestic product (GDP). Alcohol is the drug that gives rise to the greatest cost in France, i.e. 115420.91 million FF (1.42% of GDP) or an expenditure per capita of 1966 FF in 1997. Alcohol takes more than half of the social cost of drugs to society. The greatest share of the social cost of alcohol comes from the loss of productivity (57555.66 million FF), due to premature death (53168.60 million FF), morbidity (3884.0 million FF) and imprisonment (503.06 million FF). Tobacco leads to a social cost of 89256.90 million FF, that is an expenditure per capita of 1520.56 FF or 1.1% of GDP. Productivity losses amount to 50446.70 million FF, with losses of 42765.80 million FF as a result of premature death and 7680.90 million FF linked to morbidity. Health care costs for tobacco occupy second place at 26973.70 million FF. Illicit drugs generate a social cost of 13350.28 million FF, that is an expenditure per capita of 227.43 FF or 0.16% of GDP. Productivity losses reach 6099.19 million FF, with 5246.92 million FF linked to imprisonment and 852.27 million FF to premature death. The cost of enforcing the law for illicit drugs occupies second place at 3911.46 million FF, followed by health care costs of 1524.51 million FF.
CONCLUSION: Substance abuse exact a considerable toll from French society in terms of illness, injury, death and economic costs. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12566794     DOI: 10.1159/000067730

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  18 in total

1.  Crisis, suicide and labour productivity losses in Spain.

Authors:  Berta Rivera; Bruno Casal; Luis Currais
Journal:  Eur J Health Econ       Date:  2016-01-22

2.  The economic gains of achieving reduced alcohol consumption targets for Australia.

Authors:  Anne Magnus; Dominique Cadilhac; Lauren Sheppard; Toby Cumming; Dora Pearce; Rob Carter
Journal:  Am J Public Health       Date:  2012-05-17       Impact factor: 9.308

3.  Social cost of heavy drinking and alcohol dependence in high-income countries.

Authors:  Satya Mohapatra; Jayadeep Patra; Svetlana Popova; Amy Duhig; Jürgen Rehm
Journal:  Int J Public Health       Date:  2009-12-19       Impact factor: 3.380

4.  Individual differences in initial sensitivity and acute tolerance predict patterns of chronic drug tolerance to nitrous-oxide-induced hypothermia in rats.

Authors:  Douglas S Ramsay; Karl J Kaiyala; Brian G Leroux; Stephen C Woods
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

5.  Mortality Rates Among Substance Use Disorder Participants in Clinical Trials: Pooled Analysis of Twenty-Two Clinical Trials Within the National Drug Abuse Treatment Clinical Trials Network.

Authors:  Robert Lindblad; Lian Hu; Neal Oden; Paul Wakim; Carmen Rosa; Paul VanVeldhuisen
Journal:  J Subst Abuse Treat       Date:  2016-08-15

6.  The economic costs of alcohol consumption in Thailand, 2006.

Authors:  Montarat Thavorncharoensap; Yot Teerawattananon; Jomkwan Yothasamut; Chanida Lertpitakpong; Khannika Thitiboonsuwan; Prapag Neramitpitagkul; Usa Chaikledkaew
Journal:  BMC Public Health       Date:  2010-06-09       Impact factor: 3.295

7.  The scope of costs in alcohol studies: Cost-of-illness studies differ from economic evaluations.

Authors:  Paul F van Gils; Heleen H Hamberg-van Reenen; Matthijs van den Berg; Luqman Tariq; G Ardine de Wit
Journal:  Cost Eff Resour Alloc       Date:  2010-07-06

8.  Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection.

Authors:  Kevin D Shield; D Maxwell Parkin; David C Whiteman; Jürgen Rehm; Vivian Viallon; Claire Marant Micallef; Paolo Vineis; Lesley Rushton; Freddie Bray; Isabelle Soerjomataram
Journal:  Curr Epidemiol Rep       Date:  2016-08-01

9.  Direct and indirect costs attributable to alcohol consumption in Germany.

Authors:  Alexander Konnopka; Hans-Helmut König
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

10.  Methods for Estimating Avoidable Costs of Excessive Alcohol Consumption.

Authors:  Beata Gavurova; Miriama Tarhanicova
Journal:  Int J Environ Res Public Health       Date:  2021-05-07       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.